It’s easy to understand why dividends are so cherished among investors, as they provide a passive income stream, help limit the impact of drawdowns in other positions, and allow for maximum returns through dividend reinvestment.In addition, a company's ability to consistently pay and increase dividend payouts reflects a stable and healthy financial position. And, of course, dividend boosts help send a positive message surrounding the long-term picture of the company, instilling confidence it can withstand n ...

Abbott Laboratories (ABT) is well-poised for growth in the coming quarters, driven by solid prospects in the core Diagnostics business. The raised 2023 outlook buoys optimism. However, forex woes and lower COVID sales impede growth.In the past six months, this Zacks Rank #3 (Hold) stock has gained 4.6% compared with 4.8% decline of the industry and a 7.8% rise of the S&P 500 composite.This renowned provider of a diversified line of healthcare products has a market capitalization of $192.36 billion. The comp ...

With smartwatches, fitness trackers, smart clothing and smart glasses, the wearable market has grown exponentially in the last few years. Per a Statista report, nearly 150 million wearables were shipped worldwide in Q3 2023 alone. However, beyond simply tracking steps or serving as smart health devices, wearables have far evolved to become one of the most attractive investment opportunities in today's market.For investors who are keen on tapping the rising prospects of prospering wearable technology within ...

John Kevin/iStock via Getty Images Let me wish you a Happy New Year once more! We have a hot list of seven stocks increasing their dividends next week on tap. This week is bolstered by Dividend King Hormel (HRL), Mastercard (MA) and the "Abbott's," Abbott Laboratories (ABT), and AbbVie (ABBV), the drug company spinoff from Abbott in 2012. For the sake of the discussion, the streaks refer to each company's growing annual dividend. I know that Abbott's history goes back over 50 years, but the rules for inclus ...

Abbott Laboratories (ABT -0.43%) is a longtime leader in the healthcare industry. The medical device specialist has been around for decades, delivering solid returns to its loyal shareholders. However, the past few years have been challenging for the company. The pandemic disrupted its business and it encountered some regulatory issues, particularly the recall of some of its baby formula products.Still, these are short-term issues that may not mean much in a few years, meaning Abbott could rebound from its ...

ABBOTT PARK, Ill., Jan. 3, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter 2023 financial results on Wednesday, Jan. 24, before the market opens.  The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day. About Abbott:Abbott is a global healthcare leader that h ...

Traders work on the floor of the New York Stock Exchange (NYSE) on the first day back since the Christmas holiday on December 26, 2023 in New York City.In each of the past 16 Decembers I have selected and invested personally in 10 of the stocks we follow with the intention of holding for just one year. These are companies that I find especially attractive in light of their valuations or their potential to benefit from economic developments. I hold an equal dollar amount in each of the positions for the foll ...

A tree with $100 U.S. banknotes as leaves. DNY59 Familiar readers are probably well aware that I am a dividend growth investor. For the last 15 years, I have known about the strategy. It wasn't until I finished my first two years of undergrad and began to generate excess income that I started investing, however. But in the last six years, I have been laser-focused on stuffing my portfolio with many of the best businesses in the world. This is because I have both theoretically and practically found that owni ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-2189 ABBOTT LABORATORIES An Illinois Corporation I.R.S. Employer Identification No. 36-0698440 100 Abbott Park Road Abbott Park, ...

Abbott Laboratories (NYSE:ABT) Q3 2023 Earnings Call Transcript October 18, 2023 9:00 AM ET Company Participants Mike Comilla - Vice President, Investor Relations Robert Ford - Chairman and Chief Executive Officer Philip Boudreau - Senior Vice President, Finance and Chief Financial Officer Conference Call Participants Joshua Jennings - TD Cowen Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Danielle Antalffy - UBS Joanne Wuensch - Citibank Vijay Kumar - Evercore ISI Matt Miksic - Barclays Jayson Bed ...